Current concepts of erythema nodosum: from etiology to management strategy
https://doi.org/10.14412/1996-7012-2026-2-13-20
Abstract
Erythema nodosum (EN) is the most common type of septal panniculitis without signs of vasculitis. The clinical picture is characterized by painful erythematous nodules predominantly localized on the shins. Although the etiology of EN often remains unknown, the disease is based on a delayed-type hypersensitivity reaction to various antigenic stimuli. Since EN may be the first marker of a serious systemic disorder, ruling out a secondary nature of the disease is of fundamental importance. A wide range of possible etiological factors requires a thorough targeted evaluation of the patient to verify the diagnosis.
The authors present a diagnostic algorithm developed by them that will help optimize the initial assessment of patients with EN. Current approaches to the treatment of this condition are discussed.
Keywords
About the Authors
O. N. EgorovaRussian Federation
Olga Nikolaevna Egorova
34A, Kashirskoe Shosse, Moscow 115522
61/2, Shchepkina Street, Moscow 129110
B. S. Belov
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
M. V. Datsina
Russian Federation
8, Trubetskaya Street, Build. 2, Moscow 119048
G. M. Tarasova
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
References
1. Willan R. On cutaneous diseases. Vol. 1. London: J. Johnson; 1808.
2. Franzen C. Leopold Mozart and the first description of erythema nodosum. Arch Dermatol. 2008 Aug;144(8):1049-50. doi: 10.1001/archderm.144.8.1049.
3. Белов БС, Егорова ОН, Карпова ЮА, Балабанова РМ. Узловатая эритема: современные аспекты. Клиническая ревматология. 2010;(4):66-72. Belov BS, Egorova ON, Karpova YuA, Balabanova RM. Erythema nodosum: current aspects. Klinicheskaya revmatologiya. 2010;(4): 66-72. (In Russ.).
4. Шапошников ОК. Хроническая узловатая эритема. Ленинград. 1971. C. 3-42. Shaposhnikov OK. Chronic erythema nodosum. Leningrad. 1971. P. 3-42.
5. Иванов ОЛ. Кожные и венерические болезни. Москва; 1998. C. 167-198. Ivanov OL. Skin and venereal diseases. Moscow; 1998. P. 167-198.
6. Тареев ЕМ, Корнев БМ, Моисеев ВС. Узловатая эритема в клинике внутренних болезней. Терапевтический архив. 1986;58(6):36-9. Tareev EM, Kornev BM, Moiseev VS. Erythema nodosum in the Clinic of Internal Diseases. Terapevticheskii arkhiv. 1986;58(6): 36-9. (In Russ.).
7. Mert A, Kumbasar H, Ozaras R, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol. 2007 Jul-Aug; 25(4):563-70.
8. Hafsi W, Badri T. Erythema Nodosum. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan. 2022 Nov 28.
9. Perez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema Nodosum: A Practical Approach and Diagnostic Algorithm. Am J Clin Dermatol. 2021 May;22(3):367-378. doi: 10.1007/s40257-021-00592-w.
10. Егорова ОН, Белов БС. Узловатая эритема при ревматических заболеваниях. Медицинский совет. 2019;(6):95-99. Egorova ON, Belov BS. Erythema nodosum in rheumatic diseases. Meditsinskii sovet. 2019;(6):95-99. (In Russ.).
11. Li W, Zheng S, Yan X. Extensively distributed erythema nodosum in VEXAS syndrome. Lancet Haematol. 2025 Sep;12(9):e768. doi: 10.1016/S2352-3026(25)00164-4.
12. Blake T, Manahan M, Rodins K. Erythema nodosum – a review of an uncommon panniculitis. Dermatol Online J. 2014 Apr 16; 20(4):22376.
13. Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000 Mar;43(3):584-92. doi: 10.1002/1529-0131(200003)43:3<584::AID-ANR15>3.0.CO;2-6.
14. Mert A, Ozaras R, Tabak F, et al. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36(6-7):424-7. doi: 10.1080/00365540410027184.
15. Jain K, Pradhan P, Kar HK, et al. Clinical and immunological predictors of chronicity in erythema nodosum. Indian J Dermatol Venereol Leprol. 2025 May-Jun;91(Supplementary 1): S1-S7. doi: 10.25259/IJDVL_1626_2024.
16. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases: a study of 129 cases. Int J Dermatol. 1998 Sep; 37(9):667-72. doi: 10.1046/j.1365-4362.1998.00316.x.
17. Savushkina NM, Egorova ON, Glukhova SI, Belov BS. Erythema nodosum as a type of septal panniculitis in rheumatology practice: assessment of course and outcomes. Meditsinskii sovet. 2016;(11):128-134. (In Russ.).
18. Kakourou T, Drosatou P, Psychou F et al. Erythema nodosum in children: a prospective study. J Am Acad Dermatol. 2001 Jan;44(1): 17-21. doi: 10.1067/mjd.2001.110877.
19. Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007 Mar 1;75(5):695-700.
20. Elkayam O, Caspi D, Segal R, et al. Familial erythema nodosum. Arthritis Rheum. 1991 Sep;34(9):1177-9. doi: 10.1002/art.1780340915.
21. Labunski S, Posern G, Ludwig S, et al. Tumour necrosis factor-alpha promoter poly morphism in erythema nodosum. Acta Derm Venereol. Jan-Feb 2001;81(1):18-21. doi: 10.1080/00015550116912.
22. Amoli MM, Ollier WER, Lueiro M, et al. Lack of association between ICAM-1 gene polymorphisms and biopsy-proven erythema nodosum. J Rheumatol. 2004 Feb;31(2):403-5.
23. Krylov MYu, Egorova ON, Belov BS. Gene tic aspects of panniculites in the Russian po pulation (pilot study). Nauchno-praktiches-kaya revmatologiya. 2016;54(5):553-6. (In Russ.).
24. Krylov MYu, Egorova ON, Konovalova NV, Varlamov DA. The role of polymorphisms rs12218 of the SAA1 gene, rs1205 of the CRP gene, and rs7574865 of the STAT4 gene in the formation of predisposition to panniculitis in the Russian cohort of patients (pilot study). Modern Rheumatology Journal. 2022;16(4):21- 26. (In Russ.). doi:10.14412/1996-7012-2022-4-21-26.
25. Requena L, Sanchez Yus E. Erythema nodosum. Semin Cutan Med Surg. 2007 Jun;26(2): 114-25. doi: 10.1016/j.sder.2007.02.009.
26. Jones JV, Cumming RH, Asplin CM. Evidence for circulating immune complexes in erythema nodosum and early sarcoidosis. Ann N Y Acad Sci. 1976:278:212-9. doi: 10.1111/j.1749-6632.1976.tb47032.x.
27. Akdis AC, Kilicturgay K, Helvaci S, et al. Immunological evaluation of erythema nodosum in tularaemia. Br J Dermatol. 1993 Sep; 129(3):275-9. doi: 10.1111/j.1365-2133.1993.tb11846.x.
28. Nunnery E, Persellin RH, Pope RM. Lack of circulating immune complexes in uncomplicated erythema nodosum. J Rheumatol. 1983 Dec;10(6):991-4.
29. Demirkesen C, Tüzüner N, Senocak М, et al. Comparative study of adhesion molecule expression in nodular lesions of Behcet syndrome and other forms of panniculitis. Am J Clin Pathol. 2008 Jul;130(1):28-33. doi: 10.1309/3YJG2AWU06H0NX8G.
30. Kunz M, Beutel S, Brocker E. Leucocyte activation in erythema nodosum. Clin Exp Dermatol. 1999 Sep;24(5):396-401. doi: 10.1046/j.1365-2230.1999.00511.x.
31. De Simone C, Caldarola G, Scaldaferri F, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016 May;55(5):e289-94. doi: 10.1111/ijd.13212.
32. Egorova ON, Belov BS. Erythema nodosum: diagnostic issues. Vrach. 2019;30(2):75-79. (In Russ.).
33. Molina-Ruiz AM, Requena L. Erythema nodosum. Med Clin (Barc). 2016 Jul 15; 147(2):81-6. doi: 10.1016/j.medcli.2016.03.038.
34. Mana J, Marcoval J. Erythema nodosum. Clin Dermatol. 2007 May-Jun;25(3):288-94. doi: 10.1016/j.clindermatol.2007.03.006.
35. Thurber S, Kohler S. Histopathologic spectrum of erythema nodosum. J Cutan Pathol. 2006 Jan;33(1):18-26. doi: 10.1111/j.0303-6987.2006.00402.x.
Review
For citations:
Egorova ON, Belov BS, Datsina MV, Tarasova GM. Current concepts of erythema nodosum: from etiology to management strategy. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2026;20(2):13-20. (In Russ.) https://doi.org/10.14412/1996-7012-2026-2-13-20
JATS XML




































